You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 8, August 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (81)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Self-Report Scale to Help Make Psychiatric Diagnoses

The Psychiatric Diagnostic Screening Questionnaire

Mark Zimmerman, MD; Jill I. Mattia, PhD

Arch Gen Psychiatry. 2001;58:787-794.

Background  The Psychiatric Diagnostic Screening Questionnaire (PDSQ) is a brief, psychometrically strong, self-report scale designed to screen for the most common DSM-IV Axis I disorders encountered in outpatient mental health settings. In the present report, we describe the diagnostic performance (sensitivity, specificity, and positive and negative predictive values) of the PDSQ in an outpatient setting.

Methods  Six hundred thirty psychiatric outpatients presenting for treatment were evaluated with the Structured Clinical Interview for DSM-IV after completing the PDSQ. Patients arrived approximately 20 minutes before the scheduled time of the appointment to complete the scale. Diagnostic raters were blind to responses on the scale.

Results  The PDSQ's subscales' diagnostic performance varied in a predictable manner according to the cutoff score—as the threshold for case identification increased, subscale sensitivity decreased and specificity increased. Mean subscale sensitivities of 80%, 85%, and 90% resulted in mean subscale specificities of 78%, 73%, and 66%, respectively, and negative predictive values of 95%, 96%, and 97%. Receiver operating curves were determined for each subscale and all areas under the curve were significant.

Conclusions  The PDSQ is a diagnostic aid designed to be used in clinical practice to facilitate the efficiency of conducting initial diagnostic evaluations. From a clinical perspective, it is most important that a diagnostic aid have good sensitivity, so that most cases are detected, and high negative predictive value, so that most noncases on the measure are indeed noncases. Our results indicate that most of the PDSQ subscales were able to achieve this goal.


From the Department of Psychiatry and Human Behavior, Brown University School of Medicine, Rhode Island Hospital, Providence.

Reprints: Mark Zimmerman, MD, Department of Psychiatry, Rhode Island Hospital, 235 Plain St, Suite 501, Providence, RI 02905 (e-mail: mzimmerman{at}lifespan.org).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Validation of a Brief Screening Instrument for Identifying Psychiatric Disorders Among Newly Incarcerated Adults
Ford et al.
Psychiatr. Serv. 2009;60:842-846.
ABSTRACT | FULL TEXT  

Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report
Wisniewski et al.
Am. J. Psychiatry 2009;166:599-607.
ABSTRACT | FULL TEXT  

Depression Outcomes of Spanish- and English-Speaking Hispanic Outpatients in STAR*D
Lesser et al.
Psychiatr. Serv. 2008;59:1273-1284.
ABSTRACT | FULL TEXT  

Selecting Among Second-Step Antidepressant Medication Monotherapies: Predictive Value of Clinical, Demographic, or First-Step Treatment Features
Rush et al.
Arch Gen Psychiatry 2008;65:870-880.
ABSTRACT | FULL TEXT  

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report
Fava et al.
Am. J. Psychiatry 2008;165:342-351.
ABSTRACT | FULL TEXT  

Explaining Patients' Beliefs About the Necessity and Harmfulness of Antidepressants
Aikens et al.
Ann Fam Med 2008;6:23-29.
ABSTRACT | FULL TEXT  

Major Depressive Disorder and Comorbid Cardiac Disease: Is There a Depressive Subtype With Greater Cardiovascular Morbidity? Results From the STAR*D Study
Fraguas et al.
Psychosomatics 2007;48:418-425.
ABSTRACT | FULL TEXT  

CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders: A Validation Study
Sacks et al.
Criminal Justice and Behavior 2007;34:1198-1215.
ABSTRACT  

Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major Depression
Hu et al.
Arch Gen Psychiatry 2007;64:783-792.
ABSTRACT | FULL TEXT  

CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): A Pilot Study
Sacks et al.
The Prison Journal 2007;87:86-110.
ABSTRACT  

Major Depression Symptoms in Primary Care and Psychiatric Care Settings: A Cross-Sectional Analysis
Gaynes et al.
Ann Fam Med 2007;5:126-134.
ABSTRACT | FULL TEXT  

A Comparison of Lithium and T3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
Nierenberg et al.
Am. J. Psychiatry 2006;163:1519-1530.
ABSTRACT | FULL TEXT  

Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
McGrath et al.
Am. J. Psychiatry 2006;163:1531-1541.
ABSTRACT | FULL TEXT  

A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
Fava et al.
Am. J. Psychiatry 2006;163:1161-1172.
ABSTRACT | FULL TEXT  

A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7.
Spitzer et al.
Arch Intern Med 2006;166:1092-1097.
ABSTRACT | FULL TEXT  

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush et al.
NEJM 2006;354:1231-1242.
ABSTRACT | FULL TEXT  

Availability of Behavioral Health Treatment for Women in Prison
Blitz et al.
Psychiatr. Serv. 2006;57:356-360.
ABSTRACT | FULL TEXT  

Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
Trivedi et al.
Am. J. Psychiatry 2006;163:28-40.
ABSTRACT | FULL TEXT  

Development and preliminary assessment of the measurement properties of the Seating Identification Tool (SIT)1
Miller et al.
Clin Rehabil 2004;18:317-325.
ABSTRACT  

Generalized Anxiety Disorder in Patients With Major Depression: Is DSM-IV's Hierarchy Correct?
Zimmerman and Chelminski
Am. J. Psychiatry 2003;160:504-512.
ABSTRACT | FULL TEXT  

OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs. 2003;6:e1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.